Furuta Kenji, Kohata Yukie, Fujiwara Yasuhiro, Sugimoto Mitsushige, Uotani Takahiro, Yamade Mihoko, Sahara Shu, Ichikawa Hitomi, Furuta Takahisa, Nio Kenta, Iwakiri Ryuichi, Inamori Masahiko, Kawamura Osamu, Kusano Motoyasu, Kato Mototsugu, Kawami Noriyuki, Iwakiri Katsuhiko, Takeuchi Toshihisa, Higuchi Kazuhide, Aimi Masahito, Naora Kohji, Fujimoto Kazuma, Arakawa Tetsuo, Kinoshita Yoshikazu
Department of Gastroenterology and Hepatology, Shimane University School of Medicine, 89-1 Enya-cho, Izumo, Shimane 693-8501, Japan.
Department of Gastroenterology, Osaka City University Graduate School of Medicine, 1-5-7 Asahi-cho, Abeno-ku, Osaka 545-8586, Japan.
J Clin Biochem Nutr. 2014 Nov;55(3):178-83. doi: 10.3164/jcbn.14-41. Epub 2014 Oct 4.
Comparisons between the acid inhibitory effects of rabeprazole and esomeprazole after single oral administration with standard doses have not been previously presented. We examined intra-gastric pH after oral administrations of these two proton pump inhibitors using 24-h pH monitoring. Fifty-four normal volunteers not infected by Helicobacter pylori were investigated. Using a cross-over design, we administered 10 mg of rabeprazole or 20 mg of esomeprazole in 27 at 30 min after supper and in the remaining 27 subjects at 15 min before supper, and performed 24-h pH monitoring. Intra-gastric pH data were nearly identical when the proton pump inhibitors were taken after meals. Even if the data were compared in different CYP2C19 genotypes, rabeprazole and esomeprazole did not show the difference. In poor metabolizer, both of the drugs showed stronger acid inhibition. When taken before meals, intra-gastric pH after esomeprazole administration was slightly but not significantly higher than that observed after rabeprazole administration not only in daytime but also in nighttime period. In conclusion, rabeprazole and esomeprazole were similarly effective when administered after a meal.
此前尚未有关于标准剂量单次口服后雷贝拉唑和埃索美拉唑抑酸效果比较的报道。我们通过24小时pH监测,研究了口服这两种质子泵抑制剂后的胃内pH值。对54名未感染幽门螺杆菌的正常志愿者进行了调查。采用交叉设计,在27名受试者晚餐后30分钟给予10毫克雷贝拉唑或20毫克埃索美拉唑,在其余27名受试者晚餐前15分钟给予相同药物,并进行24小时pH监测。当质子泵抑制剂在餐后服用时,胃内pH值数据几乎相同。即使在不同的CYP2C19基因型中比较数据,雷贝拉唑和埃索美拉唑也未显示出差异。在代谢不良者中,两种药物均显示出更强的抑酸作用。当在餐前服用时,埃索美拉唑给药后的胃内pH值不仅在白天而且在夜间均略高于雷贝拉唑给药后观察到的pH值,但差异不显著。总之,雷贝拉唑和埃索美拉唑在餐后给药时效果相似。